Virbac has launched a new diagnostic test combination for detecting felines viruses, enabling the rapid detection of FeLV antigens, anti-FIV and anti-FCoV (feline coronavirus) antibodies in 15 minutes.

Speed-Trio-2Speed Trio is part of Virbac’s in-house diagnostic range and is designed to facilitate the diagnosis of immunosuppressive diseases, such as FIP.

Logical step

When a cat tests positive for FCoV and either FeLV or FIV, there is an increased risk of developing FIP; therefore, serological testing for all three diseases is the logical step, says Virbac.

The Speed range has been enhanced to improve the readability of the tests and the brightness of the test bands.

Product manager Madeline Haynes said: “The Speed range, which has been proven in practice for more than 20 years, offers a comprehensive suite of in-house diagnostic tests, which are easy to perform and highly cost-effective to use in practice.

“Speed Trio is not only a unique test combination that helps to facilitate diagnosis of immunosuppressive diseases, but also boosts client satisfaction and can support practice profitability.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Hany Elsheikha discusses the clinical impact of this parasite, as well as approaches for treating and preventing infestation, regarding canine and feline patients.

27 mins

Debbie Gow and Hilary Jackson discuss the options available for using these types of therapies, including the various protocols and side effects.

28 mins

Glen Cousquer and Kenneth Boyd consider ethical decision-making in exotic and wildlife medicine, focusing on key terms and the human-animal bond.

36 mins

More companion animal studies and research go under the spotlight in Alex Gough's latest Research Review.

12 mins

Ross Tiffin reports on his visit to Vets4Pets Lisburn Longstone and how it has succeeded as a feline friendly clinic.

11 mins

A vet whose research established diabetes mellitus (DM) in one-in-four UK cats is caused by a pituitary gland tumour has begun a collaboration with human medical experts that has potentially “huge” health implications.

5 mins